6 results match your criteria: "Department of Surgery Shiga University of Medical Science Otsu Japan.[Affiliation]"
Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma?
Ann Gastroenterol Surg
September 2024
Second Department of Surgery Wakayama Medical University, School of Medicine Wakayama Japan.
Article Synopsis
- * Analyzing data from 1183 patients, it found that completing 6 months of postoperative adjuvant therapy significantly improved overall, disease-specific, and recurrence-free survival, especially for high-risk patients.
- * Additionally, neoadjuvant therapy showed benefits for those with borderline resectable IPMC, and any treatment for recurrence after surgery was linked to longer survival compared to no treatment.
Aim: Antiseptics used at surgical sites are vital to preventing surgical site infections (SSI). In this study, a comparative investigation of the novel antiseptics olanexidine gluconate (OG) and povidone-iodine (PI) was conducted to determine whether OG is more effective than PI against SSI after gastrointestinal surgery.
Methods: This prospective, randomized, single-blind, interventional, single-center study was conducted between August 2018 and February 2021.
Efficacy and safety of neoadjuvant nab-paclitaxel plus gemcitabine therapy in patients with borderline resectable pancreatic cancer: A multicenter single-arm phase II study (NAC-GA trial).
Ann Gastroenterol Surg
November 2023
Department of Cancer Immunology Wakayama Medical University Wakayama Japan.
Article Synopsis
- Nab-paclitaxel plus gemcitabine (GnP-NAT) was tested as a neoadjuvant therapy in a phase II trial involving 61 patients with borderline resectable pancreatic cancer, focusing on overall survival and disease progression.
- The results showed a median overall survival of 25.2 months and a significant resection rate, although 73.8% of patients experienced serious side effects (grade 3/4 events).
- The study suggests GnP-NAT is a promising treatment, but highlights caution for patients with previous pulmonary issues and emphasizes the need for further research into its safety and effectiveness.
p16 has been used as a surrogate marker for human papillomavirus (HPV)-related tumours. However, it remains unclear whether p16 is also a potential marker for pulmonary tumours. Herein, we report the case of an 80-year-old woman with a history of papillary squamous cell carcinoma of the uterine cervix, presenting with a left pulmonary tumour.
View Article and Find Full Text PDFPurpose: This retrospective study evaluated our hypothesis that high tumor budding (≥10 buds) may help determine the appropriate T category for more accurate staging of intrahepatic cholangiocarcinoma (ICC).
Methods: We analyzed the clinical and histopathologic data of 235 consecutive patients with histologically confirmed ICC following hepatectomy at five university hospitals in the Kansai region of Japan between January 2009 and December 2020. ICC staging was based on the Liver Cancer Study Group of Japan (LCSGJ) staging system, 6th edition.
A 64-year-old man presented to the emergency department with a chief complaint of epigastric pain that improved with vomiting. He was initially treated for gastrointestinal disease, but computed tomography (CT) showed a mediastinal haematoma and contrast-enhanced CT and bronchial arteriography showed a bronchial aneurysm. Bronchial artery aneurysm is a rare but potentially life-threatening condition that can lead to haemorrhagic shock if it ruptures.
View Article and Find Full Text PDF